DE69232002D1 - Immunoassays unter Verwendung von markierten Hapten-Analogen - Google Patents

Immunoassays unter Verwendung von markierten Hapten-Analogen

Info

Publication number
DE69232002D1
DE69232002D1 DE69232002T DE69232002T DE69232002D1 DE 69232002 D1 DE69232002 D1 DE 69232002D1 DE 69232002 T DE69232002 T DE 69232002T DE 69232002 T DE69232002 T DE 69232002T DE 69232002 D1 DE69232002 D1 DE 69232002D1
Authority
DE
Germany
Prior art keywords
immunoassays
drug
labeled hapten
label
labeled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232002T
Other languages
English (en)
Other versions
DE69232002T2 (de
Inventor
Susan Jean Danielson
Barbara A Brummond
Marsha D Oenick
Ignazio Salvatore Ponticello
David Alan Hilborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Johnson and Johnson Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Clinical Diagnostics Inc filed Critical Johnson and Johnson Clinical Diagnostics Inc
Publication of DE69232002D1 publication Critical patent/DE69232002D1/de
Application granted granted Critical
Publication of DE69232002T2 publication Critical patent/DE69232002T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69232002T 1991-06-07 1992-06-02 Immunoassays unter Verwendung von markierten Hapten-Analogen Expired - Lifetime DE69232002T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71232891A 1991-06-07 1991-06-07
US85143692A 1992-03-16 1992-03-16

Publications (2)

Publication Number Publication Date
DE69232002D1 true DE69232002D1 (de) 2001-09-20
DE69232002T2 DE69232002T2 (de) 2002-06-06

Family

ID=27108808

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232002T Expired - Lifetime DE69232002T2 (de) 1991-06-07 1992-06-02 Immunoassays unter Verwendung von markierten Hapten-Analogen

Country Status (5)

Country Link
US (1) US5601994A (de)
EP (1) EP0517327B1 (de)
JP (1) JP3190730B2 (de)
AT (1) ATE204385T1 (de)
DE (1) DE69232002T2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0576095B1 (de) * 1992-06-26 1999-01-27 Johnson & Johnson Clinical Diagnostics, Inc. Immunotests unter Verwendung von markierten Thyronin-Analogen
EP0584854B1 (de) * 1992-08-07 1998-01-07 Johnson & Johnson Clinical Diagnostics, Inc. Immunoassays unter Verwendung von, mit Meerrettich-Peroxidase markierten Carbamazepin-Analogen
US5565326A (en) 1994-05-31 1996-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Separation-free specific binding assays using anti-inhibitor antibodies
US5650324A (en) 1994-05-31 1997-07-22 Johnson & Johnson Clinical Diagnostics, Inc. Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
US5589344A (en) * 1994-06-15 1996-12-31 Johnson & Johnson Clinical Diagnostics, Inc. Test kit and method for competitive specific binding assay
AU697785B2 (en) 1994-07-19 1998-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Analytical element,composition and method using modified apo-horseradish peroxidase
ES2167278B1 (es) * 2000-10-24 2003-08-16 Univ Murcia Enzima con actividad peroxidasa aislada de la alcachofa (cynara scolymus, l.) procedimiento para su aislamiento y purificacion y aplicaciones.
US8133743B2 (en) 2007-10-19 2012-03-13 Roche Diagnostics Operations, Inc. Phenobarbital derivatives useful in immunoassay
CA2882595C (en) 2012-08-21 2019-06-04 Ortho-Clinical Diagnostics, Inc. Antibodies to olanzapine haptens and use thereof
EP2888284B1 (de) 2012-08-21 2022-07-06 Janssen Pharmaceutica NV Antikörper gegen risperidon-haptene und verwendungen davon
ES2691092T3 (es) 2012-08-21 2018-11-23 Janssen Pharmaceutica Nv Anticuerpos contra la risperidona y uso de los mismos
AU2013305938B2 (en) 2012-08-21 2017-08-17 Saladax Biomedical Inc. Antibodies to paliperidone haptens and use thereof
CN104736561B (zh) 2012-08-21 2018-06-12 詹森药业有限公司 帕潘立酮的抗体及其用途
WO2017106501A1 (en) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Antibodies to risperidone and use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875011A (en) * 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US4065354A (en) * 1974-10-10 1977-12-27 Syva Company Lysozyme conjugates for enzyme immunoassays
US4213964A (en) * 1978-12-07 1980-07-22 Miles Laboratories, Inc. Diphenylhydantoin antibodies
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
US4404366A (en) * 1980-05-06 1983-09-13 Miles Laboratories, Inc. Beta-galactosyl-umbelliferone-labeled hapten conjugates
NZ199629A (en) * 1981-02-17 1984-11-09 Abbott Lab Fluorescent polarisation immunoassay and certain substituted carboxy fluoresceins
US4378428A (en) * 1981-03-30 1983-03-29 Baker Instruments Corporation Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
US4447529A (en) * 1981-07-06 1984-05-08 Miles Laboratories, Inc. Preparing homogeneous specific binding assay element to avoid premature reaction
US4752568A (en) * 1986-01-13 1988-06-21 Eastman Kodak Company Labeled hydantoin conjugate and its use in analytical element and immunoassays
CA1300499C (en) * 1987-08-03 1992-05-12 Susan J. Danielson Water-insoluble reagent, elements containing same and methods of use
ES2104566T3 (es) * 1989-03-10 1997-10-16 Hoffmann La Roche Reactivos para la determinacion de drogas.
US5096838A (en) * 1989-11-27 1992-03-17 Abbott Laboratories Barbiturate assay compositions and methods
US5162219A (en) * 1990-06-18 1992-11-10 Eastman Kodak Company Preparation of amine-enriched proteins having an increased isoelectric point

Also Published As

Publication number Publication date
JPH0627108A (ja) 1994-02-04
ATE204385T1 (de) 2001-09-15
EP0517327A3 (en) 1993-05-05
EP0517327A2 (de) 1992-12-09
EP0517327B1 (de) 2001-08-16
US5601994A (en) 1997-02-11
JP3190730B2 (ja) 2001-07-23
DE69232002T2 (de) 2002-06-06

Similar Documents

Publication Publication Date Title
DE69232002D1 (de) Immunoassays unter Verwendung von markierten Hapten-Analogen
DE69329318D1 (de) Immunotestverfahren unter Verwendung von Mikropartikel enthaltenden, unterschiedlichen, nachweisbaren Substanzen
DE68919565D1 (de) Immuntestverfahren unter Verwendung magnetischer Markerteilchen.
NO851516L (no) Krysstang-kvadrupolkilde for akustisk broennlogging.
DE68922243D1 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde.
KR890006584A (ko) 헤테로이작용성 커플링제
ATE208042T1 (de) Hapten-analoge zur verwendung in immunoassays
DE69232001T2 (de) Markierte Hapten-Analoge zur Verwendung in Immunoassays
DE69323244D1 (de) Immunotests unter Verwendung von markierten Thyronin-Analogen
DE68914094D1 (de) Immunoanalyseverfahren.
IT209826Z2 (it) Dispositivo a ponte per il rilevamento dell'assetto di veicoli.
DE69021921D1 (de) Monoklonale Antikörper gegen den C-Terminus von ANP.
DE69008406D1 (de) N-Hydroxycarbyloxy-Derivate von s-Triazinen mit gehinderter Aminogruppe.
DE69316112T2 (de) Immunoassays unter Verwendung von, mit Meerrettich-Peroxidase markierten Carbamazepin-Analogen
DE69000908D1 (de) Leichtes transportables brueckenteil zur ueberwindung von graeben.
FR2700074B1 (fr) Dispositif pour l'alimentation d'ampoules basse tension.
IT8719647A0 (it) Processo per la sintesi dell'epsiloncaprolattame.
DE68904524D1 (de) Verfahren zur synthese von n,n'-dithio(sulfonamiden).
IT1213801B (it) Metodo per il recupero dell'oro dal fango refluo dalla lavorazione orafa.
SE8601010D0 (sv) Klockspik
IT229997Y1 (it) Dispositivo atto a fermare temporaneamente orologi a cinturino, purche' apribile, su qualunque capo di vestiario
DK128893A (da) Immunassayfremgangsmåde til påvisning af antistoffer mod vira
SE8600970L (sv) Anordning vid sagklinga
KR890014497A (ko) 우라실리보뉴클레오티드 가수분해물로부터 우라실의 분리법
FR2634320B1 (fr) Dispositif semi-conducteur pourvu d'electrodes reliees par un systeme a pont en l'air

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 517327

Country of ref document: EP